PuSH - Publication Server of Helmholtz Zentrum München

Radermacher, K. A.* ; Wingler, K.* ; Langauser, F.* ; Altenhöfer, S.* ; Kleikers, P.* ; Hermans, J. J. R.* ; Hrabě de Angelis, M. ; Kleinschnitz, C.* ; Schmidt, H. H. H. W.*

Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.

Antioxid. Redox Signal. 18, 1418-1427 (2013)
Publ. Version/Full Text PDF DOI
Open Access Green as soon as Postprint is submitted to ZB.
Abstract Significance: Stroke, a leading cause of death and disability, poses a substantial burden for patients, relatives, and our healthcare systems. Only one drug is approved for treating stroke, and more than 30 contraindications exclude its use in 90% of all patients. Thus, new treatments are urgently needed. In this review, we discuss oxidative stress as a pathomechanism of poststroke neurodegeneration and the inhibition of its source, type 4 nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX4), as a conceptual breakthrough in stroke therapy. Recent Advances: Among potential sources of reactive oxygen species (ROS), the NOXes stand out as the only enzyme family that is solely dedicated to forming ROS. In rodents, three cerebrovascular NOXes exist: the superoxide-forming NOX1 and 2 and the hydrogen peroxide-forming NOX4. Studies using NOX1 knockout mice gave conflicting results, which overall do not point to a role for this isoform. Several reports find NOX2 to be relevant in stroke, albeit to variable and moderate degrees. In our hands, NOX4 is, by far, the major source of oxidative stress and neurodegeneration on ischemic stroke. Critical Issues: We critically discuss the tools that have been used to validate the roles of NOX in stroke. We also highlight the relevance of different animal models and the need for advanced quality control in preclinical stroke research. Future Directions: The development of isoform-specific NOX inhibitors presents a precious tool for further clarifying the role and drugability of NOX homologues. This could pave the avenue for the first clinically effective neuroprotectant applied poststroke, and even beyond this, stroke could provide a proof of principle for antioxidative stress therapy. Antioxid. Redox Signal. 00, 000-000.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Keywords Acute Ischemic-stroke ; Nadph Oxidase ; Cerebral-ischemia ; Brain ; Apocynin ; Injury ; Reperfusion ; Inhibitor ; Disease ; Mouse
ISSN (print) / ISBN 1523-0864
e-ISSN 1557-7716
Quellenangaben Volume: 18, Issue: 12, Pages: 1418-1427 Article Number: , Supplement: ,
Publisher Mary Ann Liebert
Reviewing status Peer reviewed